The Alkaline Water Company (NASDAQ:WTER) today announced the signing of a landmark deal with potential to transform its brand name and portfolio. The company is set to merge with AQUAhydrate®, Inc, a Los-Angeles based private manufacturer of premium bottled water. The deal brings with it,...
Aytu BioScience (NASDAQ: AYTU), a specialty pharmaceutical Company engaged in developing solutions for unmet needs in areas such as virility, reproductive health, severe cough and insomnia, has entered into a definitive agreement with Innovus Pharmaceuticals (OTCQB: INNV) for acquisition of the company. The deal is...
Nonalcoholic Steatohepatitis (NASH) is a form of Non-Alcoholic Fatty Liver Disease (NAFLD) and is characterized by the buildup of FAT in the liver. This condition is marked by hepatitis, inflammation, cell damage and fat deposits in the liver. These fat deposits can cause fibrosis of...
Inspired Entertainment (NASDAQ: INSE), a supplier of business-to-business virtual sports and server based gaming worldwide, announced the signing of an agreement with VEEPIO, the mobile technology arm of the NFL Alumni. The deal will enable Inspired to use the name, brand, image, persona and likenesses...
Neurotrope Inc, (NASDAQ: NTRP) announced a setback, with Bryostatin, its lead candidate for the treatment of Alzheimer’s, failing to meet its clinical endpoints of its mid-stage study. The Topline results from the confirmatory Phase 2 study of Bryostatin-1, in moderate to severe Alzheimer’s, failed to achieve...
Medicine Man Technologies (OTCQX: MDCL), a company providing cannabis consulting, nutrients and supplies, announced that it has entered into a binding term sheet agreement with Starbuds, to purchase four dispensaries in Colorado, in consideration for a cash, stock and a deferred payment deal. These four...
CRISPR, which is an acronym for Clustered Regularly Interspaced Short Palindromic Repeats, is a revolutionary genome editing approach that helps change an individual’s DNA, by altering it at a specific location. The Crisper-Cas9, short for clustered regularly interspaced short palindromic repeats and CRISPR-associated protein 9,...
CytoDyn Inc (OTCQB: CYDY), a clinical stage biotechnology company, announced the filing of an Investigational Drug License (IND) for treatment of NASH with Leronlimab. The drug candidate is a humanized IgG4 mAb CCR5 antagonist that has been granted the Fast Track designation by the FDA...
KemPharm (NASDAQ: KMPH), a specialty pharmaceutical company, has entered into a collaboration and licensing agreement with an affiliate of Gurnet Point Capital (GPC) in exchange for an upfront payment of $10 million, in addition to receiving pre-approval cost reimbursements, regulatory milestone and sales milestone amounting...
Identiv (NASDAQ: INVE), a leading player in the global physical access control and identification systems, is set to unveil its comprehensive End-to-End Security Platform for Physical and Logical Access Control, Video and Data Analytics, and RFID and NFC Solutions at the Global Security Exchange (GSX)...
